When someone is diagnosed with cancer, it is one of the most devastating things to hear, leaving many questions unanswered. Where is the tumor? Can this illness be treated? How advanced is the disease? Finding out what therapies best fit the patients’ needs often follows this serious prognosis. In this Patient Power program, similar questions and concerns surrounding treatment progresses, are answered by highly knowledgeable experts at the Seattle Cancer Care Alliance (SCCA). The SCCA makes a continuous effort to always bring patients the latest in state-of-the-art treatments and procedures. Joining Andrew Schorr is, Dr. Renato Martins, medical oncologist and assistant professor of medicine at the University of Washington Medical Center and Seattle Cancer Care Alliance. As a lung cancer specialist, Dr. Martins, helps us understand the major progress in the treatment of lung cancer and how multidisciplinary approaches are helping patients to see what approach is best for them. You’ll hear Dr. Martins explain how most of this progress comes from a new understanding of the nature of a specific lung cancer.
Dr. Martins says, “most of the progress comes through a better understanding of the biology of lung cancer, as well as the recognition that there are special types of lung cancer that may be driven by a specific mechanism and that we can perhaps interfere with these mechanisms, leading to better outcome to our patients.”
Andrew and Dr. Martins explore other areas of high interest for patients, such as clinical trials. Exciting new trials like the Puget Sound Oncology Group Trial or PSOG, is allowing doctors from around the country to join forces and fine tune methods of how to better treat patients. Dr. Martins clarifies that while it is highly recommended for patients to enter clinical trials, some lung cancer patients shy away in fear of the outcome. With a new understanding of a special genetic abnormality growth on some lung cancer tumors, experts are exploring how this understanding can be used as a model in treating other specific types of lung cancer.
While most questions after the diagnosis are difficult, nothing outweighs the most feared questions surrounding survival time. Dr. Martins discusses the difficulty in predicting survival time for lung cancer patients and how radiologic methods are being used to understand the progression. Andrew and Dr. Martins also discuss new methods like operating through small surgical ports resulting in a complete surgical resection. Listen to Dr. Martins discuss how much progress has been made in the treatment of lung cancer, how smokers can significantly lower their risks for this illness, who radiation therapy is right for, and finally how second opinions are giving patients the best path to success.
|
Renato Martins, M.D., M.P.H.
Medical Oncologist, Associate Professor of Medicine, Seattle Cancer Care Alliance, UW Medicine
Dr. Martins is a medical oncologist and associate professor of medicine, as well as medical director of the Thoracic/Head & Neck Cancer Program at the University of Washington. He is also medical director of Outpatient Services at the Seattle Cancer Care Alliance. He received his medical degree from Federal University of Rio de Janeiro in his home country of Brazil,...
more >
|
|
|

